Regenerative Medicine Stocks List

Regenerative Medicine Stocks Recent News

Date Stock Title
Jul 3 ABBV AbbVie Q2 IPR&D expenses to lower EPS by $0.52
Jul 3 ABBV Company News for Jul 3, 2024
Jul 3 ABBV AbbVie: A Hold Again (Rating Downgrade)
Jul 2 ABBV With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Jul 2 ABBV AbbVie to Host Second-Quarter 2024 Earnings Conference Call
Jul 2 HUMA While institutions own 20% of Humacyte, Inc. (NASDAQ:HUMA), individual investors are its largest shareholders with 50% ownership
Jul 1 RCEL AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
Jul 1 HUMA Humacyte stock rallies 19% on FDA RMAT designation
Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
Jul 1 HUMA Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)
Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
Jul 1 ABBV 3 Magnificent Stocks Retirees Can Buy and Hold Forever
Jul 1 ABBV 10 clinical trials to watch in the second half of 2024
Jun 29 ABBV How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
Jun 28 ABBV How Medicare drug price negotiations could hit pharma stocks
Jun 28 ABBV Coherus offloads Humira biosimilar Yusimry for $40m
Jun 28 ABBV AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
Jun 28 ABBV AbbVie, Genmab blood cancer therapy endorsed in EU
Regenerative Medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. If a regenerated organ's cells would be derived from the patient's own tissue or cells, this would potentially solve the problem of the shortage of organs available for donation, and the problem of organ transplant rejection.Some of the biomedical approaches within the field of regenerative medicine may involve the use of stem cells. Examples include the injection of stem cells or progenitor cells obtained through directed differentiation (cell therapies); the induction of regeneration by biologically active molecules administered alone or as a secretion by infused cells (immunomodulation therapy); and transplantation of in vitro grown organs and tissues (tissue engineering).

Browse All Tags